Journal of Cardiovascular Computed Tomography
Volume 3, Issue 6 , Pages 412-414 , November 2009

Persistent fifth aortic arch in a patient with a history of intrauterine thalidomide exposure

Received 29 May 2009 ,Accepted 25 July 2009.

References 

  1. Smithells R, Newman C. Recognition of thalidomide defects. J Med Genet. 1992;29:716–723
  2. Khan S, Nihil M. Clinical presentation of persistent fifth aortic arch. Tex Heart Inst J. 2006;33:361–364
  3. Lee ML, Chiu IS, Fang W, Chen SJ, Wang YM, Chaou WT. Isolated infundibuloarterial inversion and fifth aortic arch in an infant: a newly recognized cardiovascular phenotypes with chromosome 22q11 deletion. Int J Cardiol. 1999;71:89–91
  4. Gilani S. Cardiovascular malformations in the chick embryo induced by thalidomide. Toxicol Appl Pharmacol. 1973;25:77–83

 Conflict of interest: Dr. Abbara reports receiving research support from Bracco, being on the medical advisory boards of Partners Imaging and Magellan Healthcare Inc., and being a consultant for Perceptive Informatics, Inc, and EZEM. The other authors report no conflicts of interest.

PII: S1934-5925(09)00406-7

doi: 10.1016/j.jcct.2009.07.004

Journal of Cardiovascular Computed Tomography
Volume 3, Issue 6 , Pages 412-414 , November 2009

Article Tools

* Image Usage & Resolution